Hepatocellular carcinoma and aflatoxin in Sudan: The way forward
Hepatocellular carcinoma (HCC) is the sixth most common type of cancer and the third leading cause of death worldwide. It is especially prevalent in developing countries, with around 80% of cases occurring in Asia and Africa. Aflatoxin B1 is a well-documented risk factor for HCC, among other factors...
Saved in:
Main Author: | Moawia Mohammed Ali Elhassan (Author) |
---|---|
Format: | Book |
Published: |
Health and Social Sciences Research Institute - South Sudan (HSSRI-SS),
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatocellular carcinoma in South Sudan: possible aetiologies, presentation, diagnostic challenges and ways forward
by: Charles O.C. Langoya, et al.
Published: (2016) -
Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico
by: Leonardo S Lino-Silva, et al.
Published: (2022) -
Tadalafil inhibits elevated glutamic oxaloacetic transaminase during alcohol aflatoxin induced hepatocellular carcinoma in rats
by: Divya Rawat, et al.
Published: (2020) -
Lessons Learned from Sudan Ebola Virus Disease (SUDV) Preparedness in Rwanda: A Comprehensive Review and Way Forward
by: Edson Rwagasore, et al.
Published: (2023) -
Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis
by: Liyan Huang, et al.
Published: (2023)